Wake Forest University School of Medicine has been awarded a $3.3 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study and develop a treatment for primary hyperoxaluria (PH). This rare genetic disorder causes kidney stones and other serious health problems.
